() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: PVOT

Pivot Completes C$1.1 Million Non-Brokered Private Placement and Loan Facility

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has closed a non-brokered financing consisting of a Private Placement (the "Private Placement") and Loan Facility ("Loan") for a total of C$1,100,000 and has used the proceeds to reduce its outstanding debt obligations by $750,000.
Read more

Pivot Pharma Develops Transdermal Patch for Delivery of CBD and THC

Feb. 15, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has completed the development of a controlled-release transdermal patch system for the delivery of cannabinoids. Thrudermic™ is a proven technology for penetration through the skin and reaching the blood stream without altering the skin structure.
Read more

Pivot Pharma Signs Contract Manufacturing Agreement with Growpacker Inc.

Jan. 28, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has entered into a strategic Contract Manufacturing Agreement ("the Agreement") with Growpacker Inc. ("Growpacker") to produce Pivot's differentiated and patented topical gels, creams and beverages for the California cannabis market.
Read more
Get $50 in free trades.